Robert Meyer of the FDA slammed David Graham for ignoring other risks and problems that diabetics have.
Now the Wellpoint observational data shows that Avandia patients were twice as likely to have a prior heart problem.... oh.
No statistical signficance associated with either TZD...
Subgroup analysis of monotherapy..no statistical significance.
Now the Wellpoint observational data shows that Avandia patients were twice as likely to have a prior heart problem.... oh.
No statistical signficance associated with either TZD...
Subgroup analysis of monotherapy..no statistical significance.
